Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

March 13, 2017 Cover

Volume 95, Issue 11

Three stories of creating new therapeutic molecules

Cover image:

Credit:

Full Article
Volume 95 | Issue 11

All Issues

Business

Building pharmaceutical outsourcing partnerships

Three stories of creating new therapeutic molecules

  • Electrosynthesis gives organic chemists more power

    Using electric current as a reagent streamlines reactions by avoiding hazardous reagents, generating less waste, and reducing cost

  • Nestlé, Danone look to renewable bottles

    The companies hope to crack the biobased polyester problem by working with start-up Origin Materials

  • Fraser Stoddart talks about life after the Nobel

    Northwestern professor discusses his chemistry legacy and hopes for scientists in China

ADVERTISEMENT
image name
Pharmaceuticals

Dual therapy first weakens, then kills antibiotic-resistant pathogens

The drug pentamidine disrupts the outer membrane of Gram-negative bacteria, allowing antibiotics inside to finish the job

ADVERTISEMENT
ADVERTISEMENT